Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kelly L Hayward

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Annals of Hepatology|July 19, 2023
Lower prevalence of elevated liver stiffness measurements in people with type 2 diabetes taking sodium-glucose co-transporter 2 inhibitors or glucagon-like peptide-1 receptor agonistsLucy Gracen, Withma Muthukumara, Melanie Aikebuse, et al.
BMC Gastroenterology|July 14, 2022
Poor disease knowledge is associated with higher healthcare service use and costs among patients with cirrhosis: an exploratory studyPatricia C Valery, Christina M Bernardes, Kelly L Hayward, et al.
Internal Medicine Journal|August 8, 2017
Optimising care of patients with chronic disease: patient-oriented education may improve disease knowledge and self-managementKelly L Hayward, Leigh U Horsfall, Brittany J Ruffin, et al.
BMJ Open Gastroenterology|September 18, 2020
ICD-10-AM codes for cirrhosis and related complications: key performance considerations for population and healthcare studiesKelly L Hayward, Amy L Johnson, Benjamin J Mckillen, et al.
Hepatology Communications|May 13, 2022
Patient-oriented medication education intervention has long-term benefits for people with decompensated cirrhosisKelly L Hayward, Vikas Bansal, Patricia C Valery, et al.
Trials|July 22, 2017
Patient-oriented education and medication management intervention for people with decompensated cirrhosis: study protocol for a randomized controlled trialKelly L Hayward, Jennifer H Martin, W Neil Cottrell, et al.
Drugs - Real World Outcomes|October 12, 2023
Changing Prevalence of Medication Use in People with Cirrhosis: A Retrospective Cohort Study Using Pharmaceutical Benefits Scheme DataKelly L Hayward, Rianne A Weersink, Christina M Bernardes, et al.
BMC Gastroenterology|September 14, 2016
Prevalence of medication discrepancies in patients with cirrhosis: a pilot studyKelly L Hayward, Patricia C Valery, W Neil Cottrell, et al.
Journal of Clinical Gastroenterology|July 22, 2020
Longitudinal Change in Simple Scores Identifies Fibrosis Status in People With Nonalcoholic Fatty Liver DiseaseBenjamin J McKillen, Elizabeth E Powell, Leigh U Horsfall, et al.
Patient Preference and Adherence|April 8, 2020
Development and Evaluation of the Supportive Needs Assessment Tool for Cirrhosis (SNAC)Patricia C Valery, Christina M Bernardes, Katherine A Stuart, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Annals of Hepatology|July 19, 2023
Lower prevalence of elevated liver stiffness measurements in people with type 2 diabetes taking sodium-glucose co-transporter 2 inhibitors or glucagon-like peptide-1 receptor agonistsLucy Gracen, Withma Muthukumara, Melanie Aikebuse, et al.
BMC Gastroenterology|July 14, 2022
Poor disease knowledge is associated with higher healthcare service use and costs among patients with cirrhosis: an exploratory studyPatricia C Valery, Christina M Bernardes, Kelly L Hayward, et al.
Internal Medicine Journal|August 8, 2017
Optimising care of patients with chronic disease: patient-oriented education may improve disease knowledge and self-managementKelly L Hayward, Leigh U Horsfall, Brittany J Ruffin, et al.
BMJ Open Gastroenterology|September 18, 2020
ICD-10-AM codes for cirrhosis and related complications: key performance considerations for population and healthcare studiesKelly L Hayward, Amy L Johnson, Benjamin J Mckillen, et al.
Hepatology Communications|May 13, 2022
Patient-oriented medication education intervention has long-term benefits for people with decompensated cirrhosisKelly L Hayward, Vikas Bansal, Patricia C Valery, et al.
Trials|July 22, 2017
Patient-oriented education and medication management intervention for people with decompensated cirrhosis: study protocol for a randomized controlled trialKelly L Hayward, Jennifer H Martin, W Neil Cottrell, et al.
Drugs - Real World Outcomes|October 12, 2023
Changing Prevalence of Medication Use in People with Cirrhosis: A Retrospective Cohort Study Using Pharmaceutical Benefits Scheme DataKelly L Hayward, Rianne A Weersink, Christina M Bernardes, et al.
BMC Gastroenterology|September 14, 2016
Prevalence of medication discrepancies in patients with cirrhosis: a pilot studyKelly L Hayward, Patricia C Valery, W Neil Cottrell, et al.
Journal of Clinical Gastroenterology|July 22, 2020
Longitudinal Change in Simple Scores Identifies Fibrosis Status in People With Nonalcoholic Fatty Liver DiseaseBenjamin J McKillen, Elizabeth E Powell, Leigh U Horsfall, et al.
Patient Preference and Adherence|April 8, 2020
Development and Evaluation of the Supportive Needs Assessment Tool for Cirrhosis (SNAC)Patricia C Valery, Christina M Bernardes, Katherine A Stuart, et al.
Pageof 3